Brief: Coya Therapeutics Announces Issuance Of New U.S. Patent Protecting Methods Of Producing Recombinant Human (Rh) Interleukin-2 (Aldesleukin) Liquid Formulations
02/06/2025 13:17
June 2 (Reuters) - Coya Therapeutics Inc COYA.O: COYA THERAPEUTICS ANNOUNCES ISSUANCE OF NEW U.S. PATENT PROTECTING METHODS OF PRODUCING RECOMBINANT HUMAN (RH) INTERLEUKIN-2 (ALDESLEUKIN) LIQUID FORMULATIONS COYA THERAPEUTICS INC - TO SUBMIT IND FOR COYA 302 BY END OF JUNE Source text: ID:nBw4Vc90la Further company coverage: COYA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)